ライフサイエンスコーパス: fat-free mass

1 measures (including leg impedance and trunk fat-free mass).

2 kcal/d; P = 0.02 or 0.04 when expressed per fat-free mass).

3 circumference, arm muscle circumference and fat free mass.

4 t in men and women whether related to REE or fat free mass.

5 x DeltaFFM, g/d), FM is fat mass, and FFM is fat-free mass.

6 ns and tissues, and the cellular fraction of fat-free mass.

7 that reported previously between height and fat-free mass.

8 eived health but not bone mineral density or fat-free mass.

9 promote gains in performance, strength, and fat-free mass.

10 index, and waist circumference, but not for fat-free mass.

11 th increased protein utilization and loss of fat-free mass.

12 and late pregnancy GWGs were associated with fat-free mass.

13 y expenditure in tissue other than muscle or fat-free mass.

14 al impedance analysis for the calculation of fat-free mass.

15 0.09 mmol/L), fat masses (0.60-0.64 kg), and fat-free masses (0.35-0.49 kg), but higher TGs (11-13%).

16 des (23-25%), fat masses (0.48-0.60 kg), and fat-free masses (0.50-0.77 kg) across the 4 adjustment m

17 composition variables-females: REE = 0.101 x fat-free mass + 0.025 x fat mass + 0.293 x height(3) - 0

18 - 0.185 x race + 1.643; males: REE = 0.078 x fat-free mass + 0.026 x fat mass - 2.646 x 1/height(2) -

19 after adjustment for age, sex, fat mass, and fat-free mass (1,998+/-45 vs. 1,824+/-45 kcal/24 hours).

20 lementation plus physical activity increased fat-free mass (1.7-kg gain, P < 0.001), relative skeleta

21 with the high-PA (0.0005 +/- 0.0001 mg . kg fat-free mass(-1) . min(-1)) diet.

22 .2 +/- 2.5 mg/dL, 16.3 +/- 1.2 micromol . kg fat-free mass(-1) . min(-1)) IHTG content.

23 .1 +/- 1.2 mg/dL, 16.2 +/- 1.1 micromol . kg fat-free mass(-1) . min(-1)) or high (89.2 +/- 2.5 mg/dL

24 t protein balance was -0.50 +/- 0.07 mg x kg fat-free mass(-1) x min(-1) when the patients did not re

25 not receive rhGH and -0.39 +/- 0.04 mg x kg fat-free mass(-1) x min(-1) when the patients received r

26 of glucose rate of appearance [micromol x kg fat-free mass(-1) x min(-1)] x insulin [mU/L]) was great

27 sponse to isoproterenol (6, 12 and 24 ng (kg fat-free mass)(1) min(1): %EE 11 +/- 2, 14 +/- 3, 23 +/-

28 normoxia (225 +/- 23 vs. 128 +/- 30 nmol (kg fat free mass)(-)(1) pmol l(-)(1) min(-)(1); P =0.03), a

29 oterenol (isoprenaline): 6, 12 and 24 ng (kg fat-free mass)-1 min-1) in 25 sedentary (11 males; 51+/-

30 xidant, ascorbic acid (vitamin C; 0.04 g (kg fat-free mass)-1).

31 Total body fat-free mass (175 +/- 96 vs 84 +/- 71, P < 0.001) and s

32 sed fat mass (24.0 g; 95% CI: 17.4, 30.5 g), fat-free mass (34.0 g; 95% CI: 21.4, 46.6 g), and percen

33 body mass (31 versus 36 mL/kg per minute) or fat-free mass (44 versus 51 mL/kg fat-free mass per minu

34 y mass (43 versus 31 mL. kg(-1). min(-1)) or fat-free mass (50 versus 43 mL/kg fat-free mass per minu

35 NR increased body fat-free mass (62.65% +/- 2.49% compared with 61.32% +/-

36 100% (14% versus 28%), with little change in fat-free mass (66 versus 72 kg).

37 onatal fat mass (5.2 g; 95% CI: 3.5, 6.9 g), fat-free mass (7.7 g; 95% CI: 4.5, 10.9 g), and percenta

38 loss of body mass, a 0.69 kg greater loss of fat-free mass, a 1.29% greater loss in percentage body f

39 were no differences in age, BMI Z score, or fat-free mass across tertiles.

40 y protein (4CL-TBPro)] and another that used fat-free mass, age, and sex [Wang equation-derived prote

41 0.02 mg center dot min(-1) center dot kg(-1) fat-free mass Ala92 homozygotes vs. 0.44 plus minus 0.02

42 The glucose infusion rate (adjusted for fat free mass and circulating insulin concentration) req

43 Fat-free mass and abdominal visceral fat were the primar

44 obese children, as a result of their greater fat-free mass and body fat, than in lean children.

45 ted with the corresponding reductions in leg fat-free mass and estimated leg oxygen consumption (both

46 re adjusted with the use of fat-free mass or fat-free mass and fat mass as covariates.

47 nificantly, despite significant increases in fat-free mass and fat mass between the visits.

48 dition to serial measures of body weight and fat-free mass and fat mass by dual-energy X-ray absorpti

49 increased cardiac output is related to both fat-free mass and fat mass in obesity.

50 Fat-free mass and fat mass were measured by dual-energy

51 After adjusting for gains in fat-free mass and fat mass, SMR increased by 43 +/- 123

52 ge in body composition, specifically loss of fat-free mass and gain in fat mass, in older adults is a

53 r kilogram of body weight or per kilogram of fat-free mass and in all quartiles of self-reported leis

54 he complex associations between fat mass and fat-free mass and Max(dur) in a population setting.

55 Whole-body protein synthesis per fat-free mass and muscle protein fractional synthesis ra

56 in healthy men; (2) reductions in both limb fat-free mass and oxygen consumption are related to the

57 BK(2)R expression is associated with reduced fat-free mass and quadriceps strength in COPD.

58 BK(2)R gene polymorphism is a determinant of fat-free mass and quadriceps strength in patients with C

59 Evidence suggests that fat-free mass and resting metabolic rate (RMR), but not

60 teady-state glucose utilization adjusted for fat-free mass and steady-state insulin concentration [M/

61 th age-appropriate exercise, not only boosts fat-free mass and strength but also enhances other aspec

62 ontinue to question whether the decreases in fat-free mass and total body water observed in all subje

63 he Max(dur) was 1.3 s longer per kilogram of fat-free mass and was 0.5 s shorter per kilogram of fat-

64 he Max(dur) was 2.7 s longer per kilogram of fat-free mass and was 2.8 s shorter per kilogram of fat-

65 onents (SM, residual mass, AT-free mass, and fat-free mass), and liver scaled to height with powers o

66 Sex-specific, mixed-effects models with REE, fat-free mass, and age as fixed effects were used to tes

67 y was to examine the scaling of weight, fat, fat-free mass, and bone mineral content to height.

68 346) that included related estimates of fat, fat-free mass, and bone mineral mass.

69 Dairy intake was related to sex, fat-free mass, and daily intakes of energy, protein, and

70 2), P = 0.02 for RMR; adjusted for age, sex, fat-free mass, and fat mass).

71 with CF was impaired on the basis of height, fat-free mass, and fat mass, when observed longitudinall

72 outcome measures were adult body mass index, fat-free mass, and fat mass.

73 e was associated with adult body mass index, fat-free mass, and fat mass.

74 However, body mass index also reflects fat-free mass, and few studies have examined the relatio

75 ceived testosterone had a slight increase in fat-free mass, and men in both treatment groups had an i

76 ween body mass index (in kg/m(2)), fat mass, fat-free mass, and RMR with acute (1 meal) and daily (24

77 Growth rates, fat mass, fat-free mass, and several essential amino acids were si

78 ody mass index, fat mass, relative fat mass, fat-free mass, and waist circumference at 17 y (P < 0.00

79 h hormone secretion, significantly increased fat-free mass, and was generally well tolerated.

80 x, and change in fat mass, visceral fat, and fat-free mass; and was similar in children at low, mediu

81 o age 15 y (P < 0.001), and AEE adjusted for fat-free mass appeared to decrease over the same interva

82 Fat-free mass as well as intraabdominal fat correlated t

83 of weight gained in the etanercept group was fat-free mass, as compared with only 14% in the methotre

84 The fat-free mass, as measured by whole-body potassium scann

85 ceps maximum voluntary contraction force and fat-free mass assessed by bioelectrical impedance analys

86 he boys with and without CF was observed for fat-free mass assessed by skinfold-thickness measurement

87 stress were related to lower infant percent fat-free mass at 5 months of age, particularly in offspr

88 ocity was positively associated with fat and fat-free mass at age 3 y (all P < 0.0001), whereas a lat

89 associated with higher neonatal fat mass and fat-free mass but not percentage of body fat relative to

90 ly associated with adult body mass index and fat-free mass but not with measures of adult fat mass.

91 , designed primarily to assess increments in fat-free mass by a deuterium dilution technique and chan

92 by computed tomography scan and body fat and fat-free mass by dual-energy X-ray absorptiometry.

93 rth change was more strongly associated with fat-free mass change (r(2) = 0.22, P < 0.01) than with f

94 diet vs. -4.8 kg with the low-fat diet) than fat-free mass (change, -3.3 kg vs. -2.4 kg, respectively

95 vels of resting energy expenditure and lower fat-free mass compared to healthy controls.

96 d feeding efficiency, but reduced length and fat-free mass compared with MC3R(hWT/hWT).

97 Mean fat-free mass decreased in the placebo group but increas

98 consistency of the relation between BCM and fat-free mass decreases with increasing weight loss, the

99 V-associated weight loss, the weight lost as fat-free mass depends on the initial percentage of body

100 Body mass index and fat-free mass did not differ significantly between genot

101 Increased fat-free mass did not result in changes in strength or f

102 copenia) was defined as fat-free mass index (fat-free mass divided by the square of height) <17.5 (me

103 tein at levels exceeding the RDA may protect fat-free mass during short-term weight loss.

104 Fat-free mass, energy intake, and sex accounted for 86%

105 When the model relating fat-free mass, energy intake, and sex to energy expendit

106 Fat-free mass explained the sex difference in RMR, but b

107 ndent variables such as sex, weight, height, fat-free mass, fat mass, age, and hemoglobin concentrati

108 es used for validation, model predictions of fat-free mass, fat mass, and total body water matched ac

109 After adjustment for fat-free mass, fat mass, height, overweight status, race

110 for human studies that reported the outcomes fat-free mass, fat mass, or the percentage of fat mass i

111 are tailored to metabolic variables, such as fat-free mass, fat mass, resting metabolic rate (RMR), a

112 better than single predictions at predicting fat-free mass, fat mass, total body water, and RMR.

113 l study that measured gestational-changes in fat-free mass, fat mass, total body water, and total ene

114 (HCHO: CHO ~12 g kg(-1) , EA~ 60 kcal kg(-1) fat free mass (FFM)), (2) reduced CHO but high fat avail

115 ency results in an immediate decrease in the fat free mass (FFM).

116 1.0 for serotonin levels, and.45 and.76 for fat free mass (FFM).

117 ndependent of changes in body weight (BW) or fat free mass (FFM).

118 and BMI (adjusted P < 0.001) or fat mass and fat-free mass (FFM) (+3.3%; adjusted P < 0.001)].

119 (PAEE. kg(-1). d(-1)), 3) PAEE adjusted for fat-free mass (FFM) (PAEE. kg FFM(-1). d(-1)), and 4) th

120 Comparable fat-free mass (FFM) accretion (+2% to 3% relative to bas

121 the relative importance of fat mass (FM) and fat-free mass (FFM) accretion is not well understood.

122 Relevant data adjusted for fat-free mass (FFM) also were extracted.

123 Fat-free mass (FFM) and fat mass (FM) (4-compartment mod

124 e natural longitudinal patterns of change in fat-free mass (FFM) and fat mass (FM) in older adults an

125 dy gamma counting were combined to calculate fat-free mass (FFM) and fat mass (FM) using equations ba

126 Fat-free mass (FFM) and fat mass (FM) were estimated by

127 Fat-free mass (FFM) and fat mass (FM) were estimated wit

128 Fat-free mass (FFM) and fat mass (FM) were measured by b

129 Up to age 52 y, fat-free mass (FFM) and fat mass (FM) were positively as

130 Before and after this period, fat-free mass (FFM) and fat mass were assessed by using

131 ronic obstructive pulmonary disease, loss of fat-free mass (FFM) and loss of bone mineral density (BM

132 ive equations for total body water (TBW) and fat-free mass (FFM) and to refit the best-performing mod

133 ) and activity-related EE (AEE) adjusted for fat-free mass (FFM) and total body fat, mothers' and fat

134 d the hypothesis that both fat mass (FM) and fat-free mass (FFM) are proportionately lower in childre

135 sociated with decreases in fat mass (FM) and fat-free mass (FFM) by 72.0% and 28.0%, respectively.

136 which they correspond with fat mass (FM) or fat-free mass (FFM) during infancy.This study aimed to e

137 provide reference data for fat mass (FM) and fat-free mass (FFM) from birth to the age of 6 mo from a

138 igher total and regional adiposity and lower fat-free mass (FFM) in healthy women across the adult ag

139 ge body fat (PBF), total body fat (TBF), and fat-free mass (FFM) in the adult population in the Unite

140 estigated associations between proportionate fat-free mass (FFM) loss (%FFML) during weight loss and

141 Fat-free mass (FFM) loss differed significantly by sex (

142 All studies agree that variation in fat-free mass (FFM) plays a major role, but effects of f

143 higher fat mass (FM) percentage and a lower fat-free mass (FFM) than do term infants at the time of

144 resting energy expenditure (REE) relative to fat-free mass (FFM) than do whites.

145 Fat-free mass (FFM) was assessed by deuterium dilution t

146 water (TBW) was not significantly different, fat-free mass (FFM) was significantly lower (P < 0.05),

147 Fat mass (FM) and fat-free mass (FFM) were assessed by bioimpedance.

148 d by magnetic resonance imaging, and fat and fat-free mass (FFM) were measured by dual-energy X-ray a

149 Changes in weight, fat mass (FM), and fat-free mass (FFM) were used to estimate change in ener

150 control for differences in fat mass (FM) and fat-free mass (FFM) when comparing RMR values.

151 1.3 vs. 29 +/- 3.3 ml min(-1) 100 g forearm fat-free mass (FFM)(-1) and 21.7 +/- 1.2 vs. 33.6 +/- 4.

152 %, from 38.8 +/- 1.2 to 46.0 +/- 1.0 ml x kg fat-free mass (FFM)(-1) x min(-1) (P < 0.05).

153 llowing doses: 0, 2.5, 5, and 10 micro g. kg fat-free mass (FFM)(-1).h(-1).

154 went two 180 min hyperinsulinaemic (2 mU (kg fat-free mass (FFM))(-1) min(-1)), hypoglycaemic (3.33 m

155 height, and body composition [fat mass (FM), fat-free mass (FFM), and %BF] were measured with dual-en

156 weight, waist circumference, fat mass (FM), fat-free mass (FFM), and appendicular mass by dual-energ

157 etween birth weight and later fat mass (FM), fat-free mass (FFM), and fat distribution.

158 The impact of body size, fat-free mass (FFM), and fat mass (FM) on cardiorespirat

159 ifferent effects of total body weight (TBW), fat-free mass (FFM), and fat mass (FM) on left ventricul

160 Total body mass, fat-free mass (FFM), and fat mass (FM) were assessed by

161 d body-composition [including fat mass (FM), fat-free mass (FFM), and percentage body fat (%BF) evalu

162 nce values were generated for fat mass (FM), fat-free mass (FFM), and percentage body fat (PBF) by ge

163 e kinetics under fasting and fed conditions, fat-free mass (FFM), and serum insulin were determined o

164 Fat mass (FM), fat-free mass (FFM), and weight were measured by DXA and

165 on, body mass index (BMI) z score, fat mass, fat-free mass (FFM), arm muscle circumference (AMC), for

166 eadths and measures of total body fat (TBF), fat-free mass (FFM), bone mineral content (BMC), and bon

167 nt models (2CMs) to assess fat mass (FM) and fat-free mass (FFM), but to our knowledge no study has u

168 bottom 15th percentiles of BMR, adjusted for fat-free mass (FFM), fat mass, age, and sex, were identi

169 Data from the outcome variables fat-free mass (FFM), fat mass, type I and II muscle fibe

170 ion between the weight-for-age z score (WZ), fat-free mass (FFM), percentage of body fat (%BF), and m

171 When expressed relative to fat-free mass (FFM), the MFO was 10.8 +/- 3.2 mg . min(-

172 Adaptive thermogenesis (AT) is the fat-free mass (FFM)-independent reduction of resting ene

173 riods in infancy and later fat mass (FM) and fat-free mass (FFM).

174 , and sex-specific ratio of fat mass (FM) to fat-free mass (FFM).

175 (D(FFM)) and hydration fraction (HF(FFM)) of fat-free mass (FFM).

176 eight changes because of concurrent gains in fat-free mass (FFM).

177 EE was standardized by fat-free mass (FFM).

178 0.12 mmol/L) and mitigation of reductions in fat-free mass (FFM; 0.43 kg; 95% CI: 0.09, 0.78 kg) and

179 y (6-min-walk distance [6MWD]), muscle mass (fat-free mass [FFM]), and systemic inflammation (fibrino

180 - 0.7 vs. 22.9 +/- 1.1 ml x min(-1) x kg(-1) fat-free mass [FFM]; P = 0.011) and insulin sensitivity

181 to ART initiation were BMI; height adjusted fat free mass (FFMI); height adjusted fat mass (FMI), an

182 nalyses adjusted for age, sex, fat mass, and fat-free mass, free T(3) was a positive predictor of SMR

183 The mean fat-free mass gained by the dutasteride groups was 0.6 k

184 The mean fat-free mass gained by the placebo groups was 0.8 kg (9

185 Recently, fat-free mass has been considered to be more strongly co

186 ass in both men and women and independent of fat-free mass, height, race, television watching, physic

187 orrespond with increased adiposity and lower fat-free mass in early infancy.

188 Fat-free mass in obese people contributed little to the

189 The assessment of fat mass and fat-free mass in relation to the symptom-limited maximal

190 Changes in fat-free mass in response to graded testosterone doses d

191 e mass and was 2.8 s shorter per kilogram of fat-free mass in the highest fat-mass quartile.

192 e mass and was 0.5 s shorter per kilogram of fat-free mass in the highest fat-mass quartile.

193 e initial percentage of body fat and loss of fat-free mass in the women.

194 protein); and 3) maintenance or accretion of fat-free mass--in some individuals, a moderately higher

195 at decreased (-2.2 +/- 0.7 kg; P = 0.02) and fat-free mass increased (2.5 +/- 0.6 kg; P = 0.01).

196 There was no difference in fat-free mass increment in WF or WF-L compared with CSB+

197 mass (0.91 [95% CI: 0.87 to 0.96]) but not a fat-free mass index (0.97 [95% CI: 0.92 to 1.03]).

198 Low muscle mass (sarcopenia) was defined as fat-free mass index (fat-free mass divided by the square

199 Fat-free mass index (FFMI) and fat mass index (FMI) are

200 ects without taking fat mass index (FMI) and fat-free mass index (FFMI) into account.

201 At age 6 y, fat mass index (FMI) and fat-free mass index (FFMI) were measured with dual-energ

202 for height to give fat mass index (FMI) and fat-free mass index (FFMI), respectively.

203 The mean (+/-SD) fat-free mass index (in kg/m(2)) was significantly lower

204 Thirty-three patients had a low fat-free mass index (kg/m(2)), 17 of whom had a normal b

205 lower body cell mass index (P = 0.0001) and fat-free mass index (P = 0.003) than did matched control

206 The same outcomes were generated for the fat-free mass index and fat mass index.

207 d with a lower fat mass, fat mass index, and fat-free mass index at age 3 y (all P < 0.001).

208 The fat-free mass index tended to be lower in Asians than in

209 units and 0.02-0.45 fat mass index (FMI) or fat-free mass index units per unit of change in composit

210 A high fat-free mass index was associated with only a decreased

211 mass, percentage of fat, fat mass index, and fat-free mass index were assessed.

212 we further measured fat mass index (FMI) and fat-free mass index with dual-energy X-ray absorptiometr

213 lations of body composition (fat mass index, fat-free mass index) and adiposity (body mass index, wai

214 By contrast, comparisons of fat-free mass indicated lower concentrations than the co

215 ivided by height in meters squared); fat and fat-free mass indices and percentage of body fat from bi

216 have normal-to-high body fat stores, loss of fat-free mass is independent of the initial percentage o

217 Leg blood flow normalized for leg fat-free mass is preserved with age in women taking chro

218 Body fatness, not fat-free mass, is associated with cardiovascular disease

219 MRp (MJ/d) = 0.024 x fat mass (kg) + 0.102 x fat-free mass (kg) + 0.85.

220 percentage of body fat compared with loss of fat-free mass (kg) suggested a nonlinear relation over t

221 Sex-specific centiles for fat mass (kg), fat-free mass (kg), and percentage body fat were estimat

222 on was included, TDEE (kcal/d) = 454 + 38.7 (fat-free mass, kg) - 5.4 (fat mass, kg) + 4.7 (age in y)

223 , BP control, anemia, sodium intake, income, fat-free mass, left ventricular mass index, and ejection

224 Weight, fat, and fat-free mass loss were greater in males (P < 0.001 for

225 We propose that RMR (largely determined by fat-free mass) may be a marker of energy intake and coul

226 Changes in fat and fat-free mass, measured by dual-energy X-ray absorptiome

227 Repeated measures included weight, fat mass, fat-free mass, midupper arm circumference, triceps skinf

228 t-free mass min); 95% CI: 0.4, 0.5 mumol/(kg fat-free mass min); 3 mo-mean 1.4 mumol/(kg fat-free mas

229 ed nearly 3-fold [before-mean: 0.5 mumol/(kg fat-free mass min); 95% CI: 0.4, 0.5 mumol/(kg fat-free

230 fat-free mass min); 3 mo-mean 1.4 mumol/(kg fat-free mass min); 95% CI: 0.8, 1.9 mumol/(kg fat-free

231 t-free mass min); 95% CI: 0.8, 1.9 mumol/(kg fat-free mass min); P = 0.002], and time to peak was muc

232 .4 +/- 1.2 vs. 8.1 +/- 0.8 10(-2) mg. kg(-1) fat-free mass. min(-1). microU(-1). ml(-1)).

233 (6.64 +/- 0.52 vs. 8.45 +/- 0.54 mg. kg(-1) fat-free mass. min(-1); P < 0.05 vs. FH(-)).

234 e-body protein synthesis (5.05 +/- 1.3 mg/kg fat-free mass/min versus 3.22 +/- 0.3 mg/kg fat-free mas

235 0.041 +/- 0.005 vs. 0.051 +/- 0.007 mumol/kg fat-free mass/min) (P < 0.05 for all).

236 fat-free mass/min versus 3.22 +/- 0.3 mg/kg fat-free mass/min; P < 0.05).

237 the variance of measured REE per kilogram of fat-free mass (model R(2) = 0.66, P < 0.0001).

238 comitant ingestion of whey protein (0.6 g/kg fat-free mass; n = 11) or leucine that matched the amoun

239 d with LMI and, after adjustment for sex and fat-free mass, negatively associated with FMI but not wi

240 24.3 +/- 4.2 vs. 59.6 +/- 10.0 micro mol. kg fat-free mass of the leg(-1). min(-1); P < 0.02) were al

241 ture variables were adjusted with the use of fat-free mass or fat-free mass and fat mass as covariate

242 ables (age, sex, ethnic group, fat mass, and fat-free mass or lean tissue mass) was assessed.

243 were eliminated after adjustment for either fat-free mass or muscle mass.

244 energy intake from dietary records, sex, and fat-free mass (or weight and height).

245 =0.68 for adiposity outcomes and >/=0.80 for fat-free mass outcomes.

246 Changes in body mass, fat mass, and fat-free mass over 1 y were assessed by the 3 methods.

247 s and protein-mineral mass were not changed, fat-free mass (P = 0.004) and total body water (P = 0.01

248 ormal basal metabolic rate when adjusted for fat-free mass, partial hypogonadotropic hypogonadism and

249 . infused with insulin (1.5 milliunits/kg of fat-free mass per min) while clamping glucose, amino aci

250 or high-dose insulin (0.25 and 1.5 mU/kg of fat-free mass per min, respectively), and glucose.

251 and PO (4.43 +/- 0.7 and 5.71 +/- 1.2 mg/kg fat-free mass per min, respectively), compared with a ne

252 ral balance with control (0.25 +/- 0.5 mg/kg fat-free mass per min; P = 0.002 and <0.001 for IDPN ver

253 diet group and by 7.02 mumol per kilogram of fat-free mass per minute (95% CI, 3.21 to 10.84) in the

254 from baseline, by 7.04 mumol per kilogram of fat-free mass per minute (95% confidence interval [CI],

255 +/-15.9 to 61.6+/-13.0 mumol per kilogram of fat-free mass per minute in the diet group and from 29.4

256 +/-12.6 to 54.5+/-10.4 mumol per kilogram of fat-free mass per minute in the surgery group; there was

257 (95% CI, 2.41 to 8.33) mumol per kilogram of fat-free mass per minute in the two groups, respectively

258 in(-1)) or fat-free mass (50 versus 43 mL/kg fat-free mass per minute).

259 minute) or fat-free mass (44 versus 51 mL/kg fat-free mass per minute).

260 c correlations amongst body fat %, fat mass, fat-free mass, physical activity, glycemic traits and 17

261 Leg fat-free mass (r = -0.48) and estimated leg oxygen consu

262 were shown for TBF (r = 0.32, P = 0.035) and fat-free mass (r = 0.34, P = 0.025) between values (kg)

263 reflect prenatal and maternal influences on fat-free mass rather than on fat mass in older people.

264 s: body weight, BMI, fat mass, visceral fat, fat-free mass, resting metabolic rate (RMR), VO2max, lei

265 g/kg were associated with 0.60 kg additional fat-free mass retention compared with diets with protein

266 The primary outcome was change in fat-free mass; secondary outcomes: changes in fat mass,

267 Body weights and fat free mass significantly decreased in the placebo gro

268 ucation, higher body mass index, and greater fat-free mass, social desirability, and dissatisfaction

269 controlled physical activity would increase fat-free mass, strength, physical function, and quality

270 ference than for waist circumference and for fat-free mass than for fat mass, which was explained lar

271 included in the model in place of whole-body fat-free mass, the ethnic difference in REE decreased.

272 Adjusted for fat-free mass, the relationship was stronger (linear tre

273 The greatest predictor of ERs was fat-free mass, then ambulatory status.

274 Age, height, body weight, BMI, fat-free mass, visceral fat, energy expenditure, respira

275 Femoral blood flow normalized for leg fat-free mass was 17 % lower (P < 0.01) in the postmenop

276 igher TDEE and RMR than did AA children when fat-free mass was considered.

277 Loss of fat-free mass was dependent on the initial percentage of

278 Fat-free mass was estimated by dual-energy X-ray absorpt

279 In formula-fed infants, fat-free mass was higher at 3-4 mo [mean difference (95%

280 When trunk fat-free mass was included in the model in place of whol

281 oportion of weight loss due to reductions in fat-free mass was lower (P<0.05) and the loss of fat mas

282 y the Max(dur), although the contribution of fat-free mass was positive in thinner people.

283 Leg fat-free mass was reduced in IMB (mean +/- SEM: -3.6% +/

284 The hydration of the fat-free mass was significantly higher in the fatter chi

285 Leg fat-free mass was smaller in the postmenopausal groups (

286 Questionnaire), and EI (food buffet or menu).Fat-free mass was the best predictor of acute EI (R(2) =

287 As a percentage of fat-free mass, water decreases throughout infancy wherea

288 linic visits, at which time weight, fat, and fat-free mass were determined.

289 cumference, hip circumference, fat mass, and fat-free mass were linearly related to incident AF.

290 Fat and fat-free mass were measured by dual-energy X-ray absorpt

291 To adjust for body size, fat mass and fat-free mass were normalized for height and expressed a

292 tween the dutasteride and placebo groups for fat-free mass were not significant (P = .18).

293 nd total body water, and 4-component fat and fat-free masses were calculated.

294 y genetically correlated with body fat % and fat-free mass, whereas (2) attention-deficit/hyperactivi

295 e while serum creatinine was correlated with fat-free mass, which is a marker of muscle mass.

296 ying in dietary protein on 2-year changes in fat-free mass, whole body total percentage of fat mass,

297 Fat mass modified the association of fat-free mass with the Max(dur) (2-way interaction P < 0

298 however, when the analysis was adjusted for fat-free mass, women had significantly higher TEE than d

299 TGD) (6.9 +/- 0.7 to 9.2 +/- 0.8 mg x kg(-1) fat-free mass x min(-1)) (all P < 0.001), and decreased

300 Percent body fat, fat-free mass z scores, and triceps skinfold z scores de